Molecular mechanism of endothelial and vascular aging: implications for cardiovascular disease
GG Camici, G Savarese, A Akhmedov… - European heart …, 2015 - academic.oup.com
… , the prevalence of cardiovascular (CV) and cerebrovascular (CBV) diseases rises with
age. … the molecular pathways of aging as well as age-associated CV and CBV diseases. …
age. … the molecular pathways of aging as well as age-associated CV and CBV diseases. …
Diabetes, oxidative stress, molecular mechanism, and cardiovascular disease–an overview
V Selvaraju, M Joshi, S Suresh… - … mechanisms and …, 2012 - Taylor & Francis
… oxidative stress are hallmarks of the molecular mechanisms responsible for cardiovascular
disease. Among several oxidative stress-mediated mechanisms that have been proposed, …
disease. Among several oxidative stress-mediated mechanisms that have been proposed, …
Molecular mechanisms of vascular effects of high‐density lipoprotein: alterations in cardiovascular disease
C Besler, TF Lüscher, U Landmesser - EMBO molecular medicine, 2012 - embopress.org
Low high‐density lipoprotein (HDL)‐cholesterol levels are associated with an increased risk
of coronary artery disease (CAD) and myocardial infarction, which has triggered the …
of coronary artery disease (CAD) and myocardial infarction, which has triggered the …
Molecular mechanisms of nitric oxide regulation. Potential relevance to cardiovascular disease.
… NO in Cardiovascular Disease … additional mechanisms through which NO affects blood
pressure.64 Clinical studies suggesting abnormalitiesin the NO system in cardiovascular disease …
pressure.64 Clinical studies suggesting abnormalitiesin the NO system in cardiovascular disease …
Molecular mechanisms of cardiovascular disease in OSAHS: the oxidative stress link
… Circulating adhesion molecules released from the endothelium are considered as markers
of active atherosclerotic diseases and as predictors of future cardiovascular disease 81. …
of active atherosclerotic diseases and as predictors of future cardiovascular disease 81. …
[HTML][HTML] Uric acid and cardiovascular disease: an update from molecular mechanism to clinical perspective
W Yu, JD Cheng - Frontiers in pharmacology, 2020 - frontiersin.org
… on the latest cellular and molecular findings of cardiovascular disease associated with
hyperuricemia and clinical data about the efficacy of ULT in patients with cardiovascular disease. …
hyperuricemia and clinical data about the efficacy of ULT in patients with cardiovascular disease. …
Biomarkers of cardiovascular disease: molecular basis and practical considerations
RS Vasan - Circulation, 2006 - Am Heart Assoc
… conditions promptly and accurately, and to effectively prognosticate and treat patients with
disease. This review provides an overview of the molecular basis of biomarker discovery and …
disease. This review provides an overview of the molecular basis of biomarker discovery and …
Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications
CE Berry, JM Hare - The Journal of physiology, 2004 - Wiley Online Library
… pathophysiology of cardiovascular disease. Biochemical, molecular and pharmacological …
) as a source of reactive oxygen species in the cardiovascular system. XOR is a member of the …
) as a source of reactive oxygen species in the cardiovascular system. XOR is a member of the …
Tissue factor in cardiovascular diseases: molecular mechanisms and clinical implications
J Steffel, TF Lüscher, FC Tanner - Circulation, 2006 - Am Heart Assoc
… involved in the pathogenesis of cardiovascular diseases. Therefore, therapeutic strategies
… molecular regulation of TF expression emphasizing the role of TF in cardiovascular diseases …
… molecular regulation of TF expression emphasizing the role of TF in cardiovascular diseases …
n-3 Fatty acids and cardiovascular disease: Actions and molecular mechanisms
C Torrejon, UJ Jung, RJ Deckelbaum - Prostaglandins, leukotrienes and …, 2007 - Elsevier
… , cardiac excitability, platelet function, triglyceride blood levels, blood pressure and the stability
of atheroma plaques. The molecular mechanisms … and elucidating these mechanisms is …
of atheroma plaques. The molecular mechanisms … and elucidating these mechanisms is …
相关搜索
- pathogenic mechanism cardiovascular disease
- basic mechanisms cardiovascular disease
- fatty acids cardiovascular disease
- oxidative stress cardiovascular disease
- implications for cardiovascular disease
- uric acid cardiovascular disease
- molecular mechanisms physiology and diseases
- mechanisms of protection cardiovascular disease
- molecular mechanisms alterations in cardiovascular disease
- nitric oxide in cardiovascular diseases
- associated cardiovascular diseases
- diabetic cardiovascular disease
- cardiovascular disease morbidity and mortality
- predictors of cardiovascular disease
- possible treatment cardiovascular diseases
- vascular aging cardiovascular disease